Table 1 Demographic and clinical parameters of patients included in the study.

From: Biomarker candidates for progression and clinical management of COVID-19 associated pneumonia at time of admission

 

Non-critical

N = 10

Critical

N = 13

All

N = 23

Gender—male

6 (60.0%)

8 (61.5%)

14 (60.9%)

Age at admission (years)

56.54 (41.94, 77.14)

61.09 (29.16, 69.91

60.59 (29.16, 77.14)

Hospitalization (days)

5.50 (4.00, 9.00)

15.50 (9.00, 31.00)

10.50 (4.00, 31.00)

Obesity

0 (0.0%)

1 (7.7%)

1 (4.3%)

Arterial hypertension

2 (20.0%)

3 (23.1%)

5 (21.7%)

Diabetes mellitus

0 (0.0%)

0 (0.0%)

0 (0.0%)

Hyperlipidaemia

1 (10.0%)

3 (23.1%)

4 (17.4%)

Glucocorticoid’s therapy

0 (0.0%)

13 (100.0%)

13 (56.5%)

Tocilizumab therapy

0 (0.0%)

12 (92.3%)

12 (52.2%)

Non-invasive mechanical ventilation

0 (0.0%)

9 (69.2%)

9 (39.1%)

  1. Frequencies and percentages are used to summarize categorical variables, while median and the range (minimum and maximum values) are used for continuous variables.